Earli
PrivateLast Round
Series B
Apr 23, 2026
Total Funding Raised
$128M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Earli is a biotechnology company that develops cancer-programmable genetic constructs that activate exclusively in cancer cells to produce synthetic biomarkers for early detection and personalized treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Earli Comparables
Compare Earli with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sunbird Bio | 81% | |
| Mercy BioAnalytics | 75% | |
| Harbinger Health | 75% |
Earli Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 23, 2026 | ||||
| VC Round | Aug 15, 2025 | ||||
| Seed | Oct 15, 2024 | ||||
| Strategic | Aug 19, 2024 | ||||
| Series A | Jan 12, 2021 | ||||
Seed | Sep 1, 2018 |
Key People
Founding team and executive leadership
Earli Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Strategic, Series A, VC Round, Seed |
| Breyer Capital | Series A |
| Perceptive Advisors | Series A, Strategic, VC Round |
| Han River Partners | Strategic, VC Round |
| Khosla Ventures | Strategic, VC Round, Series A |
| ZhenFund | Seed |
| Zeev Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 48% MoM.
- Apr 23, 2026
$60M round completed.
Earli Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Earli's valuation, stock price, and market status.
Is Earli a public or private company?
Earli is a private company.
What is the current stock price of Earli?
Earli is a private company with no public stock price. No recent secondary market data is available.
How much is Earli worth (valuation)?
Valuation information for Earli is not publicly available.
Can I buy Earli stock?
Earli shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Earli's last funding round?
Earli's most recent funding round was Seed on October 15, 2024.
Who are the main investors in Earli?
Key investors in Earli include Andreessen Horowitz, Khosla Ventures, Zeev Ventures, Accenture Ventures.
Will Earli IPO soon?
No public IPO plans have been announced for Earli.
How can I track Earli secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Earli's secondary market activity and sign up for updates.